These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Functional exploration of the liver with sulfobromophthalein (BSF)]. Pippi L; Toti M; Alegente G; Frosini G; Lombardini L Quad Sclavo Diagn; 1972 Sep; 8(3):829-54. PubMed ID: 4671771 [No Abstract] [Full Text] [Related]
6. [Graphic analysis and mathematic model of blood clearance curves of bromsulphalein: the hepatic fixation PF gradient]. Toulet J; Pagniez R Rev Int Hepatol; 1968; 18(4):537-64. PubMed ID: 5688212 [No Abstract] [Full Text] [Related]
7. [Prevention and rehabilitation of liver diseases]. Kuntz E Munch Med Wochenschr; 1972 Feb; 114(5):165-73. PubMed ID: 4258705 [No Abstract] [Full Text] [Related]
8. [Oral galactose tolerance test in liver diseases. Studies on technics and on the evaluation of results]. Hennecke A; König KJ; Südhof H Dtsch Med Wochenschr; 1972 Jan; 97(4):109-14 passim. PubMed ID: 5008209 [No Abstract] [Full Text] [Related]
9. [Letter: Liver diagnosis in practice]. Thaler H Dtsch Med Wochenschr; 1976 Apr; 101(18):719-20. PubMed ID: 1261406 [No Abstract] [Full Text] [Related]
10. Liver-copper levels in liver disease: studies using neutron activation analysis. Smallwood RA; Williams HA; Rosenoer VM; Sherlock S Lancet; 1968 Dec; 2(7582):1310-3. PubMed ID: 4177386 [No Abstract] [Full Text] [Related]
11. [Liver biopsy, its contribution to clinical diagnosis]. Nesje OA; Arva P; Normann T Tidsskr Nor Laegeforen; 1975 Feb; 95(6):362-4,361. PubMed ID: 1121687 [No Abstract] [Full Text] [Related]
12. [Expert testimony in liver diseases]. Renger F Z Arztl Fortbild (Jena); 1976 Apr; 70(8):403-6. PubMed ID: 936655 [No Abstract] [Full Text] [Related]
14. [Serum adenosine desaminase in liver diseases]. Zipprich B; Nilius R; Otto L; Eismann R; Busse HJ; Peters JE Z Gesamte Inn Med; 1973 Sep; 28(18):Suppl:280-2. PubMed ID: 4766066 [No Abstract] [Full Text] [Related]
15. [Diagnostic evidence of serum beta-glucuronidase. 3. Behavior of serum beta glucuronidase activity in liver diseases in comparison owith results of other clinical-chemical studies]. Nilius R Z Gesamte Inn Med; 1971 Jun; 26(12):384-93. PubMed ID: 5570297 [No Abstract] [Full Text] [Related]
16. Serum guanase in diagnosis of hepatic disease. Grimbeek JF; Hoog JM S Afr Med J; 1970 May; 44(22):639-41. PubMed ID: 5426766 [No Abstract] [Full Text] [Related]
17. Liver disease in pregnancy. Geall MG; Webb MJ Med Clin North Am; 1974 Jul; 58(4):817-22. PubMed ID: 4841626 [No Abstract] [Full Text] [Related]
18. Clinical and laboratory differentiation of alcoholic hepatitis, fatty liver, and cirrhosis. Cline W; Reinold J; Dernbach W; Heubner T; Fardal P; Olsen WA Wis Med J; 1975 Jul; 74(7):78-80. PubMed ID: 1163055 [No Abstract] [Full Text] [Related]
19. The contribution of percutaneous liver biopsy to the management of liver disease. Bain BJ; Harris OD; Quinn RL Med J Aust; 1973 Jul; 2(4):160-3. PubMed ID: 4741341 [No Abstract] [Full Text] [Related]
20. [Limitation of the indication for laparoscopy and percutaneous liver biopsy in liver diseases]. Wildhirt E Med Klin; 1969 Feb; 64(7):287-9. PubMed ID: 5769480 [No Abstract] [Full Text] [Related] [Next] [New Search]